Literature DB >> 8634616

Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study.

S Langham1, M Thorogood, C Normand, J Muir, L Jones, G Fowler.   

Abstract

OBJECTIVE: To measure the costs and cost effectiveness of the Oxcheck cardiovascular risk factor screening and intervention programme.
DESIGN: Cost effectiveness analysis of a randomised controlled trial using clinical and economic data taken from the trial.
SETTING: Five general practices in Luton and Dunstable, England.
SUBJECTS: 2205 patients who attended a health check in 1989-90 and were scheduled for re-examination in 1992-3 (intervention group); 1916 patients who attended their initial health check in 1992-3 (control group). Participants were men and women aged 35-64 years. INTERVENTION: Health check conducted by nurse, with health education and follow up according to degree of risk. MAIN OUTCOME MEASURES: Cost of health check programme; cost per 1% reduction in coronary risk.
RESULTS: Health check and follow up cost 29.27 pounds per patient. Estimated programme cost per 1% reduction in coronary risk per participant was between 1.46 pounds and 2.25 pounds; it was nearly twice as much for men as women.
CONCLUSIONS: The cost to the practice of implementing Oxcheck-style health checks in an average sized practice of 7500 patients would be 47,000 pounds, a proportion of which could be paid for through staff pay reimbursements and Band Three health promotion target payments. This study highlights the considerable difficulties faced when calculating the costs and benefits of a health promotion programme. Economic evaluations should be integrated into the protocols of randomised controlled trials to enable judgments to be made on the relative cost effectiveness of different prevention strategies.

Entities:  

Mesh:

Year:  1996        PMID: 8634616      PMCID: PMC2351075          DOI: 10.1136/bmj.312.7041.1265

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  The Dundee coronary risk-disk for management of change in risk factors.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1991-09-28

2.  What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.

Authors:  D Wonderling; S Langham; M Buxton; C Normand; C McDermott
Journal:  BMJ       Date:  1996-05-18

3.  Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.

Authors:  D Wonderling; C McDermott; M Buxton; A L Kinmonth; S Pyke; S Thompson; D Wood
Journal:  BMJ       Date:  1996-05-18

4.  Strategies for reducing coronary risk factors in primary care: which is most cost effective?

Authors:  K Field; M Thorogood; C Silagy; C Normand; C O'Neill; J Muir
Journal:  BMJ       Date:  1995-04-29
  4 in total
  16 in total

Review 1.  Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.

Authors:  C K Chow; A C H Pell; A Walker; C O'Dowd; A F Dominiczak; J P Pell
Journal:  BMJ       Date:  2007-09-08

2.  Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.

Authors:  James P Raftery; Guiqing L Yao; Peter Murchie; Neil C Campbell; Lewis D Ritchie
Journal:  BMJ       Date:  2005-02-16

3.  Secondary prevention of coronary heart disease in primary care is cost effective.

Authors:  A McKnight; M Cupples
Journal:  BMJ       Date:  1996-08-31

4.  Cost effectiveness of health checks. Effect of intervention was sustained.

Authors:  J Muir; L Jones; G Fowler
Journal:  BMJ       Date:  1996-09-07

5.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.

Authors:  Dalya Marks; David Wonderling; Margaret Thorogood; Helen Lambert; Steve E Humphries; H Andrew W Neil
Journal:  BMJ       Date:  2002-06-01

6.  The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care.

Authors:  J Hippisley-Cox; M Pringle
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

7.  Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  N R Campbell; E Burgess; B C Choi; G Taylor; E Wilson; J Cléroux; J G Fodor; L A Leiter; D Spence
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 8.  Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors:  T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

Review 9.  Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.

Authors:  K L Goa; L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

10.  Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.

Authors:  A Armuzzi; T Ahmad; K-L Ling; A de Silva; S Cullen; D van Heel; T R Orchard; K I Welsh; S E Marshall; D P Jewell
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.